Cargando…
Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer
Brain metastases (BM) have been closely associated with increased morbidity and poor survival outcomes in patients with non-small cell lung cancer (NSCLC). Excluding risk factors in histological subtypes, genomic alterations, including epidermal growth factor receptor mutations and anaplastic lympho...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291252/ https://www.ncbi.nlm.nih.gov/pubmed/35796015 http://dx.doi.org/10.3892/ijo.2022.5390 |